David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CALL
Deere & Co
DE
$175B
| $29.1M | 0.02% |
68,600
-35,200
| -34% | -$14.8M |
|
752
PUT
Dow Inc
DOW
$22.7B
| $29M | 0.02% |
723,100
+524,100
| +263% | +$24.5M |
|
753
PUT
Alpha Metallurgical Resources
AMR
$2.66B
| $29M | 0.02% |
145,000
+12,700
| +10% | +$2.84M |
|
754
National Vision
EYE
$1.44B
| $29M | 0.02% |
2,781,584
-638,081
| -19% | -$6.98M |
|
755
Westlake Corp
WLK
$9.78B
| $29M | 0.02% |
252,747
+190,389
| +305% | +$24.8M |
|
756
CALL
DraftKings
DKNG
$12.9B
| $29M | 0.02% |
778,700
+344,600
| +79% | +$13.7M |
|
|
FYBR
757
DELISTED
Frontier Communications
FYBR
| $28.9M | 0.02% |
834,236
+726,136
| +672% | +$25.5M |
|
758
PUT
Las Vegas Sands
LVS
$30.4B
| $28.9M | 0.02% |
563,600
+120,000
| +27% | +$6.22M |
|
759
CALL
Autodesk
ADSK
$53.7B
| $28.9M | 0.02% |
97,700
+40,400
| +71% | +$11.9M |
|
760
Merit Medical Systems
MMSI
$5.39B
| $28.8M | 0.02% |
298,262
-55,495
| -16% | -$5.53M |
|
761
Scholar Rock
SRRK
$7.09B
| $28.8M | 0.02% |
666,885
+471,111
| +241% | +$15.3M |
|
762
CALL
First Citizens BancShares
FCNCA
$24.7B
| $28.7M | 0.02% |
13,600
-9,900
| -42% | -$20.7M |
|
763
EOG Resources
EOG
$78.8B
| $28.6M | 0.02% |
233,421
+213,718
| +1,085% | +$27.3M |
|
764
IPG Photonics
IPGP
$3.01B
| $28.5M | 0.02% |
391,395
-128,066
| -25% | -$9.84M |
|
765
CALL
Bristol-Myers Squibb
BMY
$137B
| $28.4M | 0.02% |
502,500
-312,200
| -38% | -$17.4M |
|
766
SharkNinja
SN
$25.8B
| $28.2M | 0.02% |
289,254
-92,133
| -24% | -$9.4M |
|
767
Pediatrix Medical
MD
$2.16B
| $28.1M | 0.02% |
2,143,496
-182,007
| -8% | -$2.51M |
|
768
PUT
Snap
SNAP
$9.35B
| $28.1M | 0.02% |
2,606,100
+1,741,100
| +201% | +$19.6M |
|
769
Meritage Homes
MTH
$4.73B
| $28.1M | 0.02% |
364,778
+356,200
| +4,152% | +$32.5M |
|
770
Selective Insurance
SIGI
$5.52B
| $28M | 0.02% |
298,890
+6,920
| +2% | +$663K |
|
771
Nu Holdings
NU
$71.3B
| $27.9M | 0.02% |
2,694,986
-9,272,925
| -77% | -$123M |
|
772
Coeur Mining
CDE
$21.5B
| $27.9M | 0.02% |
4,871,557
+269,786
| +6% | +$1.75M |
|
773
CALL
Moderna
MRNA
$55.4B
| $27.8M | 0.02% |
667,600
-10,000
| -1% | -$478K |
|
774
Aurora
AUR
$11.4B
| $27.7M | 0.02% |
4,397,672
+656,148
| +18% | +$4.11M |
|
775
PUT
Regeneron Pharmaceuticals
REGN
$85.3B
| $27.6M | 0.02% |
+38,800
| New | +$32.6M |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.